Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Jun 1;160(11):1592–1593.

The folly of population screening for type 2 diabetes

K G Marshall
PMCID: PMC1230366  PMID: 10374003

Full Text

The Full Text of this article is available as a PDF (69.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annas G. J. Reframing the debate on health care reform by replacing our metaphors. N Engl J Med. 1995 Mar 16;332(11):744–747. doi: 10.1056/nejm199503163321112. [DOI] [PubMed] [Google Scholar]
  2. Barsky A. J. The paradox of health. N Engl J Med. 1988 Feb 18;318(7):414–418. doi: 10.1056/NEJM198802183180705. [DOI] [PubMed] [Google Scholar]
  3. Cochrane A. L., Holland W. W. Validation of screening procedures. Br Med Bull. 1971 Jan;27(1):3–8. doi: 10.1093/oxfordjournals.bmb.a070810. [DOI] [PubMed] [Google Scholar]
  4. Fitzgerald F. T. The tyranny of health. N Engl J Med. 1994 Jul 21;331(3):196–198. doi: 10.1056/NEJM199407213310312. [DOI] [PubMed] [Google Scholar]
  5. Foreyt J., Goodrick K. The ultimate triumph of obesity. Lancet. 1995 Jul 15;346(8968):134–135. doi: 10.1016/s0140-6736(95)91205-3. [DOI] [PubMed] [Google Scholar]
  6. Førde O. H. Is imposing risk awareness cultural imperialism? Soc Sci Med. 1998 Nov;47(9):1155–1159. doi: 10.1016/s0277-9536(98)00187-7. [DOI] [PubMed] [Google Scholar]
  7. Goyder E., Irwig L. Screening for diabetes: what are we really doing? BMJ. 1998 Dec 12;317(7173):1644–1646. doi: 10.1136/bmj.317.7173.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Herman J. The ethics of prevention: old twists and new. Br J Gen Pract. 1996 Sep;46(410):547–549. [PMC free article] [PubMed] [Google Scholar]
  9. Marshall K. G. Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm. CMAJ. 1996 Jul 15;155(2):169–176. [PMC free article] [PubMed] [Google Scholar]
  10. Marshall K. G. Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs. CMAJ. 1996 Aug 15;155(4):377–383. [PMC free article] [PubMed] [Google Scholar]
  11. Meador C. K. The last well person. N Engl J Med. 1994 Feb 10;330(6):440–441. doi: 10.1056/NEJM199402103300618. [DOI] [PubMed] [Google Scholar]
  12. Pyorälä K., Pedersen T. R., Kjekshus J., Faergeman O., Olsson A. G., Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care. 1997 Apr;20(4):614–620. doi: 10.2337/diacare.20.4.614. [DOI] [PubMed] [Google Scholar]
  13. Thomas L. Notes of a biology-watcher The Health-care system. N Engl J Med. 1975 Dec 11;293(24):1245–1246. doi: 10.1056/NEJM197512112932409. [DOI] [PubMed] [Google Scholar]
  14. Wing R. R., Venditti E., Jakicic J. M., Polley B. A., Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care. 1998 Mar;21(3):350–359. doi: 10.2337/diacare.21.3.350. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES